newsfilter
← Latest News
Business Wire·

Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept's CNSide™ Versus Cytology

Real-world retrospective study showed increased sensitivity for CNSide relative to standard cerebral spinal fluid (CSF) cytology in detecting leptomeningeal metastases Biocept, Inc. (NASDAQ:BIOC) ("Biocept" or the